You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

exenatide

Showing 1 - 25 of 425
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes Trial (NPM-119 (exenatide implant), Bydureon BCise (exenatide extended release))

Not yet recruiting
  • Type 2 Diabetes
  • NPM-119 (exenatide implant)
  • Bydureon BCise (exenatide extended release)
  • (no location specified)
Jan 29, 2023

Gestational Diabetes Trial (Exenatide)

Not yet recruiting
  • Gestational Diabetes
  • Exenatide
  • (no location specified)
Jul 28, 2022

Parkinson Disease Trial in Stockholm (Exenatide, Placebo)

Active, not recruiting
  • Parkinson Disease
  • Exenatide
  • Placebo
  • Stockholm, Sweden
    Academic Specialist Center, Center for Neurology, SLSO
Sep 12, 2022

Smoking Cessation, Weight Gain Trial in Houston (Exenatide 2 milligram (mg) Injection, Placebo, Nicotine patch)

Not yet recruiting
  • Smoking Cessation
  • Weight Gain
  • Exenatide 2 milligram (mg) Injection
  • +3 more
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Nov 2, 2022

Parkinson's Disease Trial in Gainesville (Exenatide)

Completed
  • Parkinson's Disease
  • Exenatide
  • Gainesville, Florida
    Laboratory for Rehabilitation Neuroscience
Sep 14, 2022

Cocaine Use Disorder Trial in Houston (Exenatide 2 mg [Bydureon], Drug Counseling)

Completed
Has Results
  • Cocaine Use Disorder
  • Exenatide 2 mg [Bydureon]
  • Drug Counseling
  • Houston, Texas
    UTHealth Behavioral and Biomedical Sciences Building
May 31, 2022

Diabetes, Type 2 Trial in San Antonio (Dapagliflozin, Exenatide, Placebo)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • San Antonio, Texas
    University of Texas Health Science Center
Sep 12, 2022

A Pan-European Post-Authorisation Safety Study: Risk of

Not yet recruiting
  • Pancreatic Cancer
  • Exenatide
  • Non-GLP-1 RA based glucose lowering drugs
  • (no location specified)
Dec 21, 2022

Parkinson's Disease Trial in London (Exenatide extended release 2mg (Bydureon))

Active, not recruiting
  • Parkinson's Disease
  • Exenatide extended release 2mg (Bydureon)
  • London, United Kingdom
    University College London Hospital
May 18, 2022

Type 2 Diabetes Trial in Lancaster (Exenatide Injection, Saline injection)

Terminated
  • Type 2 Diabetes
  • Exenatide Injection
  • Saline injection
  • Lancaster, Pennsylvania
    Amish Research Clinic
Mar 6, 2023

Euglycemia, Hypoglycemia, Hyperglycemia Trial in Philadelphia (Exenatide 0.27 ng/kg/min, Exenatide 0.41 ng/kg/min, Placebo)

Completed
Has Results
  • Euglycemia
  • +2 more
  • Exenatide 0.27 ng/kg/min
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Dec 21, 2021

Diabetes, Type 2 Trial in San Antonio (Placebo, Exenatide, Dapagliflozin)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Placebo
  • +3 more
  • San Antonio, Texas
    University Health System Texas Diabetic Institute
Apr 28, 2022

Pre-diabetes, Type 2 Diabetes Trial in Philadelphia (Exenatide, Sitagliptin, Glimepiride)

Completed
Has Results
  • Pre-diabetes
  • Type 2 Diabetes
  • Exenatide
  • +2 more
  • Philadelphia, Pennsylvania
  • +2 more
May 16, 2022

Alcohol Use Disorder Trial in Boston (Exenatide, Sham injection)

Terminated
Has Results
  • Alcohol Use Disorder
  • Exenatide
  • Sham injection
  • Boston, Massachusetts
    Boston University Psychiatry Research Center, Clinical Studies U
Jan 14, 2022

Steatosis, Liver, Type2 Diabetes Trial in Wien (Exenatide, Exenatide matching Placebo, Dapagliflozin)

Completed
  • Steatosis, Liver
  • Type2 Diabetes
  • Exenatide
  • +2 more
  • Wien, Austria
    Abt. für Endokrinologie & Stoffwechsel, Univ. Klin f. Innere Med
Apr 8, 2022

Schizophrenia, Schizoaffective Disorder Trial in Worcester (Exenatide, Placebo)

Completed
Has Results
  • Schizophrenia
  • Schizoaffective Disorder
  • Exenatide
  • Placebo
  • Worcester, Massachusetts
    UMass Medical School
Jan 4, 2022

Diabetes Trial in San Antonio (metformin\pioglitazone\exenatide, metformin, glyburide and glargine)

Active, not recruiting
  • Diabetes
  • San Antonio, Texas
    Texas Diabetes Institute
Mar 8, 2022

Type2Diabetes Trial in Chengdu (PB119)

Not yet recruiting
  • Type2Diabetes
  • Chengdu, Sichuan, China
    Jia Miao
Apr 12, 2022

Type 1 Diabetes Trial in Bronx (Exenatide, Rapid and long acting insulin, long acting insulin + rapid acting + 1.25 mcg

Completed
Has Results
  • Type 1 Diabetes
  • Exenatide
  • +2 more
  • Bronx, New York
    Albert Einstein CRC- West Campus
Jul 13, 2021

Diabetes, Type 1, Hypoglycemia, Autoimmune Diseases Trial in Miami (Anti-Thymocyte Globulin (ATG), Interleukin 2, Exenatide)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • +3 more
  • Anti-Thymocyte Globulin (ATG)
  • +7 more
  • Miami, Florida
    Diabetes Research Institute, University of Miami Miller School o
Feb 23, 2022

Endogenous Hyperinsulinism Trial in Basel (Exenatide, 0.9% saline solution)

Recruiting
  • Endogenous Hyperinsulinism
  • Exenatide
  • 0.9% saline solution
  • Basel, Switzerland
    University Hospital Basel, Division of Nuclear Medicine
May 31, 2021

Dysglycemia, Cognitive Deficit Trial in Parma (Exenatide, )

Active, not recruiting
  • Dysglycemia
  • Cognitive Deficit
  • Exenatide
  • placebo
  • Parma, Italy
  • +1 more
Aug 10, 2021

Obesity Trial in Boston (Exenatide, Placebo, Dietary counseling)

Completed
Has Results
  • Obesity
  • Exenatide
  • +2 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jun 18, 2021

Diabetes Associated With Genetic Syndrome, Wolfram Syndrome Trial (Exenatide)

Withdrawn
  • Diabetes Mellitus Associated With Genetic Syndrome
  • Wolfram Syndrome
  • Exenatide
  • (no location specified)
Mar 14, 2022

Diabetes, Type 2 Trial in Shavano Park (Exenatide 2 MG, Dapagliflozin 10 MG)

Completed
  • Diabetes Mellitus, Type 2
  • Exenatide 2 MG
  • Dapagliflozin 10 MG
  • Shavano Park, Texas
    Consano Clinical Research, LLC
Aug 24, 2021